A Multi-Center, Open-Label BMN-110 US Expanded Access Pr

Project: Research project

Project Details

Description

A Multi-Center, Open-Label BMN-110 US Expanded Access Program (BMN 110 US EAP) to Provide BMN 110 to Patients Diagnosed with MPS IVA
StatusFinished
Effective start/end date12/31/1311/30/14

Funding

  • BIOMARIN PHARMACEUTICAL, INC.